Evidence map›Paper›PMID 26059842›Full record

ArticleEuropean journal of human genetics : EJHG2016

The use of whole-exome sequencing to disentangle complex phenotypes.

Hywel J Williams, John R Hurst, Louise Ocaka, Chela James, Caroline Pao, Estelle Chanudet, Francesco Lescai, Horia C Stanescu, Robert Kleta, GOSgene and 3 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Exome sequencing identifiesMolecular vision · 2020
    Article
  6. Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  7. Article
  8. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Hywel J WilliamsCentre for Translational Omics - GOSgene, UCL Institute of Child Health, University College London, London, UK.
John R HurstUCL Respiratory Medicine, UCL Medical School, London, UK.
Louise OcakaCentre for Translational Omics - GOSgene, UCL Institute of Child Health, University College London, London, UK.
Chela JamesCentre for Translational Omics - GOSgene, UCL Institute of Child Health, University College London, London, UK.
Caroline PaoPaediatric Respiratory Medicine, Royal London Hospital, Whitechapel, London, UK.
Estelle ChanudetCentre for Translational Omics - GOSgene, UCL Institute of Child Health, University College London, London, UK.
Francesco LescaiCentre for Translational Omics - GOSgene, UCL Institute of Child Health, University College London, London, UK.
Horia C StanescuUCL Respiratory Medicine, UCL Medical School, London, UK.
Robert KletaCentre for Translational Omics - GOSgene, UCL Institute of Child Health, University College London, London, UK.
GOSgene
Elisabeth RosserDepartment of Clinical Genetics, Great Ormond St Hospital, London, UK.
Chiara BacchelliCentre for Translational Omics - GOSgene, UCL Institute of Child Health, University College London, London, UK.
Philip BealesCentre for Translational Omics - GOSgene, UCL Institute of Child Health, University College London, London, UK.
University College Hospital · GBUniversity College London · GBRoyal London Hospital · GBGreat Ormond Street Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The success of whole-exome sequencing to identify mutations causing single-gene disorders has been well documented. In contrast whole-exome sequencing has so far had limited success in the identification of variants causing more complex phenotypes that seem unlikely to be due to the disruption of a single gene. We describe a family where two male offspring of healthy first cousin parents present a complex phenotype consisting of peripheral neuropathy and bronchiectasis that has not been described previously in the literature. Due to the fact that both children had the same problems in the context of parental consanguinity we hypothesised illness resulted from either X-linked or autosomal recessive inheritance. Through the use of whole-exome sequencing we were able to simplify this complex phenotype and identified a causative mutation (p.R1070*) in the gene periaxin (PRX), a gene previously shown to cause peripheral neuropathy (Dejerine-Sottas syndrome) when this mutation is present. For the bronchiectasis phenotype we were unable to identify a causal single mutation or compound heterozygote, reflecting the heterogeneous nature of this phenotype. In conclusion, in this study we show that whole-exome sequencing has the power to disentangle complex phenotypes through the identification of causative genetic mutations for distinct clinical disorders that were previously masked.

Indexed as

ExomeFemaleHereditary Sensory and Motor NeuropathyHeterozygoteHumansMaleMembrane ProteinsMutationPedigreePeripheral Nervous System DiseasesPhenotypePolymorphism, Single NucleotideSequence Analysis, DNAMembrane Proteinsperiaxin

Identifiers

PMID26059842
PMCPMC4717198
OpenAlexW1515418977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.